1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Blood Screening Market by Technology, Product & End User - Forecasts to 2019

The blood screening market size is expected to reach $2.55 billion by 2019 from $1.5 billion in 2014, at a CAGR of 10.4%. This market is categorized on the basis of products and services, technologies, end users, and regions. On the basis of products and services, the blood screening market is categorized into instruments (hardware), reagents, and software and services. The reagents segment accounted for the largest share of the blood screening market and is expected to grow at the highest CAGR in the coming five years. The increasing adoption rate of NAT, rising number of blood donations, disposable nature of reagents, and growing demand of blood for transfusion are driving the growth of this segment.

The major factors contributing to the growth of the blood screening market include increasing number of blood donations and blood donors, increasing awareness regarding the safety of donated blood, increasing patient affordability, and increasing demand of donated blood. Furthermore, increasing adoption of NAT by governments of various countries is another major factor providing impetus for growth of this market. For instance, in 2014, the Japanese Red Cross entered into an agreement with Grifols (Spain) for nucleic acid testing (NAT) for the total blood donated in Japan. This agreement is expected to aid the growth of the blood screening market during the forecast period.

Apart from comprehensive regional and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the blood screening market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, regional focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on product portfolios of the top players in the blood screening market. The report analyzes the blood screening market by products and services, technology, end user, and region
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the blood screening market
- Competitive Assessment: In-depth assessment of the market strategies, regional and business segments, and product portfolios of the leading players in the blood screening market
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various blood screening products across regions
- Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the blood screening market

Table Of Contents

Blood Screening Market by Technology, Product and End User - Forecasts to 2019
TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.2 SECONDARY DATA 24
2.2.1 KEY DATA FROM SECONDARY SOURCES 24
2.3 PRIMARY DATA 25
2.3.1 KEY DATA FROM PRIMARY SOURCES 25
2.3.2 KEY INDUSTRY INSIGHTS 25
2.3.3 BREAKDOWN OF PRIMARIES 26
2.4 MARKET SIZE ESTIMATION 26
2.4.1 BOTTOM-UP APPROACH 26
2.4.2 TOP-DOWN APPROACH 27
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.6 MARKET SHARE ESTIMATION 29
2.7 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 BLOOD SCREENING MARKET, BY TECHNOLOGY 35
4.2 BLOOD SCREENING MARKET, BY PRODUCTS AND SERVICES 36
4.3 BLOOD SCREENING REAGENTS MARKET 37
4.4 BLOOD SCREENING ELISA MARKET 38
4.5 BLOOD SCREENING MARKET, BY END USER 39
4.6 GEOGRAPHIC SNAPSHOT 40

5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.2.1 BY TECHNOLOGY 42
5.2.2 BY PRODUCTS AND SERVICES 43
5.2.3 BY END USER 43
5.2.4 BY REGION 44
5.3 MARKET DYNAMICS 45
5.3.1 DRIVERS 45
5.3.1.1 Increasing number of blood donations and blood donors 45
5.3.1.2 Rising awareness regarding the safety of donated blood 46
5.3.1.3 Increasing affordability for NAT due to rising disposable incomes 46
5.3.1.4 Growing adoption of NAT for blood screening 46
5.3.1.5 Increasing demand of donated blood 46
5.3.1.6 Rising prevalence of infectious diseases 47
5.3.2 RESTRAINTS 48
5.3.2.1 Capital expenditure and operating costs of NAT 48
5.3.2.2 Lack of mandates for NAT in developing countries 49
5.3.2.3 Emergence of alternative technologies such as digital immunoassay 49
5.3.3 OPPORTUNITIES 50
5.3.3.1 Pathogen reduction technology 50
5.3.3.2 Microbiology screening 50
5.3.3.3 Multiplexing (single test for HIV, HBV, and HCV) 50
5.3.4 CHALLENGES 51
5.3.4.1 Price reduction 51
5.3.4.2 Lack of trained manpower 51
5.3.4.3 Regulatory challenges 51
6 INDUSTRY INSIGHTS 52
6.1 SUPPLY CHAIN ANALYSIS 52
6.2 PEST ANALYSIS 53
6.2.1 POLITICAL FACTORS 53
6.2.2 ECONOMIC FACTORS 53
6.2.3 SOCIAL FACTORS 54
6.2.4 TECHNICAL FACTORS 54
6.3 PORTER'S FIVE FORCE ANALYSIS 55
6.3.1 THREAT OF NEW ENTRANTS 55
6.3.2 THREAT OF SUBSTITUTE TECHNOLOGIES 56
6.3.3 BARGAINING POWER OF SUPPLIERS 56
6.3.4 BARGAINING POWER OF BUYERS 56
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 56
7 BLOOD SCREENING MARKET, BY TECHNOLOGY 57
7.1 INTRODUCTION 58
7.2 BLOOD SCREENING MARKET, BY VOLUME (NUMBER OF TESTS CONDUCTED) 59
7.3 NUCLEIC ACID TEST (NAT) 60
7.3.1 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 63
7.3.2 REAL-TIME POLYMERASE CHAIN REACTION (PCR) 65
7.4 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 68
7.4.1 RAPID TEST (CARD METHODOLOGY) 70
7.4.2 1ST GENERATION ELISA 72
7.4.3 2ND GENERATION ELISA 74
7.4.4 3RD GENERATION ELISA 76
7.4.5 4TH GENERATION ELISA 78
7.5 ENZYME IMMUNOASSAYS (EIAS) AND CHEMILUMINESCENT IMMUNOASSAYS (CLIAS) 81
7.6 NEXT-GENERATION SEQUENCING (NGS) 83
7.7 WESTERN BLOT ASSAY 85
8 BLOOD SCREENING MARKET, BY PRODUCTS AND SERVICES 88
8.1 INTRODUCTION 89
8.2 REAGENTS 90
8.2.1 ELISA REAGENTS 92
8.2.1.1 Immunosorbent 95
8.2.1.2 Controls 95
8.2.1.3 Conjugate (Antigen or antibody conjugated enzyme) 95
8.2.1.4 Substrate (Substrate of enzyme) 95
8.2.1.5 Sample diluents and wash solutions 96
8.2.2 NAT REAGENTS 96
8.2.2.1 Enzymes and Polymerases 99
8.2.2.2 Standards and Controls 99
8.2.2.3 Probes and Primers 99
8.2.2.4 Buffers, Nucleotides and Solutions 99
8.2.2.5 Labeling and Detection Reagents 99
8.2.3 OTHER REAGENTS 100
8.3 INSTRUMENTS (HARDWARE) 101
8.3.1 RENTAL PURCHASE 104
8.3.2 OUTRIGHT PURCHASE 104
8.4 SOFTWARE AND SERVICES 104
9 BLOOD SCREENING MARKET, BY END USER 107
9.1 INTRODUCTION 108
9.2 BLOOD BANKS 109
9.3 HOSPITALS 112
10 BLOOD SCREENING MARKET, BY REGION 115
10.1 INTRODUCTION 116
10.2 NORTH AMERICA 119
10.2.1 U.S. 122
10.2.2 CANADA 125
10.3 EUROPE 127
10.3.1 GERMANY 130
10.3.2 FRANCE 133
10.3.3 U.K. 136
10.3.4 ITALY 139
10.3.5 SPAIN 141
10.3.6 REST OF EUROPE (ROE) 145
10.4 ASIA 148
10.4.1 JAPAN 150
10.4.2 CHINA 153
10.4.3 INDIA 156
10.4.4 REST OF ASIA (ROA) 159
10.5 REST OF THE WORLD (ROW) 162
11 COMPETITIVE LANDSCAPE 166
11.1 OVERVIEW 166
11.2 MARKET SHARE ANALYSIS 167
11.2.1 MARKET SHARE ANALYSIS FOR NAT 167
11.2.2 MARKET SHARE ANALYSIS FOR BLOOD SCREENING 168
11.3 COMPETITIVE SITUATIONS AND TRENDS 169
11.3.1 NEW PRODUCT LAUNCHES 170
11.3.2 MERGERS AND ACQUISITIONS 171
11.3.3 REGULATORY APPROVALS 172
11.3.4 PARTNERSHIPS AND AGREEMENTS 173
12 COMPANY PROFILES 174
(Overview, Financials, Products and Services, Strategy, and Developments)*
12.1 INTRODUCTION 174
12.2 GRIFOLS 175
12.3 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD) 178
12.4 ABBOTT LABORATORIES 181
12.5 BIOMÉRIEUX 184
12.6 BIO-RAD LABORATORIES, INC. 187
12.7 SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG) 190
12.8 ORTHO-CLINICAL DIAGNOSTICS, INC. 192
12.9 THERMO FISHER SCIENTIFIC, INC. 194
12.10 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION) 196
12.11 BECTON, DICKINSON AND COMPANY 198
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
13 APPENDIX 200
13.1 INSIGHTS OF INDUSTRY EXPERTS 200
13.2 DISCUSSION GUIDE 201
13.3 AVAILABLE CUSTOMIZATIONS 204
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 204
13.5 RELATED REPORTS 205


LIST OF TABLES

TABLE 1 BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 58
TABLE 2 GLOBAL BLOOD SCREENING MARKET, BY VOLUME (NUMBER OF TESTS), 2014 59
TABLE 3 NORTH AMERICA: BLOOD SCREENING MARKET, BY VOLUME (NUMBER OF TESTS), 2014 59
TABLE 4 EUROPE: BLOOD SCREENING MARKET, BY VOLUME (NUMBER OF TESTS),2014 59
TABLE 5 ASIA: BLOOD SCREENING MARKET, BY VOLUME (NUMBER OF TESTS), 2014 60
TABLE 6 BLOOD SCREENING NAT TECHNOLOGY MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 61
TABLE 7 NORTH AMERICA: BLOOD SCREENING NAT TECHNOLOGY MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 62
TABLE 8 EUROPE: BLOOD SCREENING NAT TECHNOLOGY MARKET SIZE,
BY COUNTRY/REGION, 2012-2019 ($MILLION) 62
TABLE 9 ASIA: BLOOD SCREENING NAT TECHNOLOGY MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 63
TABLE 10 BLOOD SCREENING NAT TECHNOLOGY MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 63
TABLE 11 TRANSCRIPTION-MEDIATED AMPLIFICATION TECHNOLOGY MARKET SIZE,
BY REGION, 2012-2019 ($MILLION) 64
TABLE 12 NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 64
TABLE 13 EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 65
TABLE 14 ASIA: TRANSCRIPTION-MEDIATED AMPLIFICATION TECHNOLOGY MARKET SIZE,
BY COUNTRY/REGION, 2012-2019 ($MILLION) 65
TABLE 15 REAL-TIME PCR TECHNOLOGY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 66
TABLE 16 NORTH AMERICA: REAL-TIME PCR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 66
TABLE 17 EUROPE: REAL-TIME PCR TECHNOLOGY MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 67
TABLE 18 ASIA REAL-TIME PCR TECHNOLOGY MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 67
TABLE 19 ELISA MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 68
TABLE 20 NORTH AMERICA: ELISA MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 68
TABLE 21 EUROPE: ELISA MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 69
TABLE 22 ASIA: ELISA MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 69
TABLE 23 ELISA MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 70
TABLE 24 RAPID TEST (CARD METHODOLOGY) MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 70
TABLE 25 NORTH AMERICA: RAPID TEST (CARD METHODOLOGY) MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 71
TABLE 26 EUROPE: RAPID TEST (CARD METHODOLOGY) MARKET SIZE,
BY COUNTRY/REGION, 2012-2019 ($MILLION) 71
TABLE 27 ASIA: RAPID TEST (CARD METHODOLOGY) MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 72
TABLE 28 1ST GENERATION ELISA MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 72
TABLE 29 NORTH AMERICA: 1ST GENERATION ELISA MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 73
TABLE 30 EUROPE: 1ST GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 73
TABLE 31 ASIA: 1ST GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 74
TABLE 32 2ND GENERATION ELISA MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 74
TABLE 33 NORTH AMERICA: 2ND GENERATION ELISA MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 75
TABLE 34 EUROPE: 2ND GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 75
TABLE 35 ASIA: 2ND GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 76
TABLE 36 3RD GENERATION ELISA MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 76
TABLE 37 NORTH AMERICA: 3RD GENERATION ELISA MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 77
TABLE 38 EUROPE: 3RD GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 77
TABLE 39 ASIA: 3RD GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 78
TABLE 40 4TH GENERATION ELISA MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 79
TABLE 41 NORTH AMERICA: 4TH GENERATION ELISA MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 80
TABLE 42 EUROPE: 4TH GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 80
TABLE 43 ASIA: 4TH GENERATION ELISA MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 81
TABLE 44 EIAS AND CLIAS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 81
TABLE 45 NORTH AMERICA: EIAS AND CLIAS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 82
TABLE 46 EUROPE: EIAS AND CLIAS MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 82
TABLE 47 ASIA: EIAS AND CLIAS MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 83
TABLE 48 NGS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 83
TABLE 49 NORTH AMERICA: NGS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 84
TABLE 50 EUROPE: NGS MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 84
TABLE 51 ASIA: NGS MARKET SIZE, BY COUNTRY/REGION, 2012-2019 ($MILLION) 85
TABLE 52 WESTERN BLOT ASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 85
TABLE 53 NORTH AMERICA: WESTERN BLOT ASSAY MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 86
TABLE 54 EUROPE: WESTERN BLOT ASSAY MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 86
TABLE 55 ASIA: WESTERN BLOT ASSAY MARKET SIZE, BY COUNTRY/REGION,
2012-2019 ($MILLION) 87
TABLE 56 BLOOD SCREENING MARKET SIZE, BY PRODUCTS AND SERVICES,
2012-2019 ($MILLION) 89
TABLE 57 BLOOD SCREENING REAGENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 91
TABLE 58 NORTH AMERICA: BLOOD SCREENING REAGENTS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 91
TABLE 59 EUROPE: BLOOD SCREENING REAGENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 91
TABLE 60 ASIA: BLOOD SCREENING REAGENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 92
TABLE 61 BLOOD SCREENING REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 92
TABLE 62 BLOOD SCREENING ELISA REAGENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 93
TABLE 63 NORTH AMERICA: BLOOD SCREENING ELISA REAGENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 93
TABLE 64 EUROPE: BLOOD SCREENING ELISA REAGENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 94
TABLE 65 ASIA: BLOOD SCREENING ELISA REAGENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 94
TABLE 66 BLOOD SCREENING ELISA REAGENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 95
TABLE 67 BLOOD SCREENING NAT REAGENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 96
TABLE 68 NORTH AMERICA: BLOOD SCREENING NAT REAGENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 97
TABLE 69 EUROPE: BLOOD SCREENING NAT REAGENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 97
TABLE 70 ASIA: BLOOD SCREENING NAT REAGENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 98
TABLE 71 BLOOD SCREENING NAT REAGENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 99
TABLE 72 BLOOD SCREENING OTHER REAGENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 100
TABLE 73 NORTH AMERICA: BLOOD SCREENING OTHER REAGENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 100
TABLE 74 EUROPE: BLOOD SCREENING OTHER REAGENTS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 101
TABLE 75 ASIA: BLOOD SCREENING OTHER REAGENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 101
TABLE 76 BLOOD SCREENING INSTRUMENTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 102
TABLE 77 NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 102
TABLE 78 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 103
TABLE 79 ASIA: BLOOD SCREENING INSTRUMENTS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 103
TABLE 80 BLOOD SCREENING INSTRUMENTS MARKET SIZE, BY MODE OF PURCHASE,
2012-2019 ($MILLION) 104
TABLE 81 BLOOD SCREENING SOFTWARE AND SERVICES MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 105
TABLE 82 NORTH AMERICA: BLOOD SCREENING SOFTWARE AND SERVICES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 105
TABLE 83 EUROPE: BLOOD SCREENING SOFTWARE AND SERVICES MARKET SIZE,
BY REGION, 2012-2019 ($MILLION) 106
TABLE 84 ASIA: BLOOD SCREENING SOFTWARE AND SERVICES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 106
TABLE 85 BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 109
TABLE 86 BLOOD SCREENING MARKET SIZE FOR BLOOD BANKS, BY REGION,
2012-2019 ($MILLION) 110
TABLE 87 NORTH AMERICA: BLOOD SCREENING MARKET SIZE FOR BLOOD BANKS,
BY COUNTRY, 2012-2019 ($MILLION) 110
TABLE 88 EUROPE: BLOOD SCREENING MARKET SIZE FOR BLOOD BANKS, BY COUNTRY, 2012-2019 ($MILLION) 111
TABLE 89 ASIA: BLOOD SCREENING MARKET SIZE FOR BLOOD BANKS, BY COUNTRY,
2012-2019 ($MILLION) 111
TABLE 90 BLOOD SCREENING MARKET SIZE FOR HOSPITALS, BY REGION,
2012-2019 ($MILLION) 112
TABLE 91 NORTH AMERICA: BLOOD SCREENING MARKET SIZE FOR HOSPITALS,
BY COUNTRY, 2012-2019 ($MILLION) 113
TABLE 92 EUROPE: BLOOD SCREENING MARKET SIZE FOR HOSPITALS, BY COUNTRY,
2012-2019 ($MILLION) 113
TABLE 93 ASIA: BLOOD SCREENING MARKET SIZE FOR HOSPITALS, BY COUNTRY,
2012-2019 ($MILLION) 114
TABLE 94 GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 117
TABLE 95 NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 118
TABLE 96 EUROPE: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 118
TABLE 97 ASIA: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 119
TABLE 98 NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 120
TABLE 99 NORTH AMERICA: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 120
TABLE 100 NORTH AMERICA: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 121
TABLE 101 NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION) 121
TABLE 102 NORTH AMERICA: BLOOD SCREENING MARKET SIZE FOR REAGENTS,
BY TYPE, 2012-2019 ($MILLION) 122
TABLE 103 NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 122
TABLE 104 U.S.: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 123
TABLE 105 U.S.: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 123
TABLE 106 U.S.: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 123
TABLE 107 U.S.: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 124
TABLE 108 U.S.: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 124
TABLE 109 U.S.: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 124
TABLE 110 CANADA: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 125
TABLE 111 CANADA: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 125
TABLE 112 CANADA: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 126
TABLE 113 CANADA: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 126
TABLE 114 CANADA: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 127
TABLE 115 CANADA: BLOOD SCREENING MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 127
TABLE 116 EUROPE: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 128
TABLE 117 EUROPE: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 128
TABLE 118 EUROPE: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 129
TABLE 119 EUROPE: BLOOD SCREENING MARKET SIZE, BY PRODUCTS AND SERVICES,
2012-2019 ($MILLION) 129
TABLE 120 EUROPE: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 130
TABLE 121 EUROPE: BLOOD SCREENING MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 130
TABLE 122 GERMANY: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 131
TABLE 123 GERMANY: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 131
TABLE 124 GERMANY: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 132
TABLE 125 GERMANY: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 132
TABLE 126 GERMANY: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 133
TABLE 127 GERMANY: BLOOD SCREENING MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 133
TABLE 128 FRANCE: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 134
TABLE 129 FRANCE: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 134
TABLE 130 FRANCE: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 134
TABLE 131 FRANCE: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 135
TABLE 132 FRANCE: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 135
TABLE 133 FRANCE: BLOOD SCREENING MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 136
TABLE 134 U.K.: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 136
TABLE 135 U.K.: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 137
TABLE 136 U.K.: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 137
TABLE 137 U.K.: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 138
TABLE 138 U.K.: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 138
TABLE 139 U.K.: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 138
TABLE 140 ITALY: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 139
TABLE 141 ITALY: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 139
TABLE 142 ITALY: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 140
TABLE 143 ITALY: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 140
TABLE 144 ITALY: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 141
TABLE 145 ITALY: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 141
TABLE 146 SPAIN: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 142
TABLE 147 SPAIN: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 142
TABLE 148 SPAIN: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 143
TABLE 149 SPAIN: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 143
TABLE 150 SPAIN: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 144
TABLE 151 SPAIN: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 144
TABLE 152 ROE: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 145
TABLE 153 ROE: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 145
TABLE 154 ROE: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 146
TABLE 155 ROE: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 146
TABLE 156 ROE: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 147
TABLE 157 ROE: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 147
TABLE 158 ASIA: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 148
TABLE 159 ASIA: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 148
TABLE 160 ASIA: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 149
TABLE 161 ASIA: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 149
TABLE 162 ASIA: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 150
TABLE 163 ASIA: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 150
TABLE 164 JAPAN: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 151
TABLE 165 JAPAN: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 151
TABLE 166 JAPAN: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 151
TABLE 167 JAPAN: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 152
TABLE 168 JAPAN: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 152
TABLE 169 JAPAN: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 153
TABLE 170 CHINA: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 154
TABLE 171 CHINA: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 154
TABLE 172 CHINA: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 155
TABLE 173 CHINA: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 155
TABLE 174 CHINA: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 156
TABLE 175 CHINA: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 156
TABLE 176 INDIA: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 157
TABLE 177 INDIA: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 157
TABLE 178 INDIA: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 158
TABLE 179 INDIA: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 158
TABLE 180 INDIA: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 159
TABLE 181 INDIA: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 159
TABLE 182 ROA: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 160
TABLE 183 ROA: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 160
TABLE 184 ROA: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 161
TABLE 185 ROA: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 161
TABLE 186 ROA: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 162
TABLE 187 ROA: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 162
TABLE 188 ROW: BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 163
TABLE 189 ROW: BLOOD SCREENING MARKET SIZE FOR NAT, BY TYPE,
2012-2019 ($MILLION) 163
TABLE 190 ROW: BLOOD SCREENING MARKET SIZE FOR ELISA, BY TYPE,
2012-2019 ($MILLION) 164
TABLE 191 ROW: BLOOD SCREENING MARKET SIZE, BY PRODUCTS and SERVICES,
2012-2019 ($MILLION) 164
TABLE 192 ROW: BLOOD SCREENING MARKET SIZE FOR REAGENTS, BY TYPE,
2012-2019 ($MILLION) 165
TABLE 193 ROW: BLOOD SCREENING MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 165
TABLE 194 RECENT DEVELOPMENTS, 2011-2014 170
TABLE 195 RECENT DEVELOPMENTS, 2011-2014 171
TABLE 196 RECENT DEVELOPMENTS, 2011-2015 172
TABLE 197 RECENT DEVELOPMENTS, 2011-2014 173


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 23
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 26
FIGURE 3 BOTTOM-UP APPROACH 27
FIGURE 4 TOP-DOWN APPROACH 28
FIGURE 5 DATA TRIANGULATION METHODOLOGY 29
FIGURE 6 BLOOD SCREENING MARKET SNAPSHOT, BY TECHNOLOGY (2014 VS. 2019) 31
FIGURE 7 REAGENTS SEGMENT TO DOMINATE THE BLOOD SCREENING MARKET DURING THE FORECAST PERIOD 32
FIGURE 8 FOURTH-GENERATION ELISA IS LARGEST SEGMENT OF THE BLOOD SCREENING MARKET 32
FIGURE 9 BLOOD BANKS IS THE FASTEST-GROWING END-USER SEGMENT OF THE BLOOD SCREENING MARKET DURING THE FORECASTED PERIOD 33
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL BLOOD SCREENING MARKET 34
FIGURE 11 NAT SEGMENT TO OFFER ATTRACTIVE GROWTH OPPORTUNITIES 35
FIGURE 12 THE BLOOD SCREENING REAGENTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 36
FIGURE 13 NAT REAGENTS CONTRIBUTE THE HIGHEST SHARE TO THE BLOOD SCREENING REAGENTS MARKET 37
FIGURE 14 THE 4TH GENERATION ELISA SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR IN ASIA DURING THE FORECAST PERIOD 38
FIGURE 15 THE BLOOD BANKS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 39
FIGURE 16 CHINA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 40
FIGURE 17 TECHNOLOGICAL INNOVATION AND DIFFERENTIATED PRODUCTS ARE INCREASING COMPETITION AMONG MARKET PLAYERS 55
FIGURE 18 NAT TESTING WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 58
FIGURE 19 REAL-TIME PCR EXPECTED TO GROW AT A DOUBLE-DIGIT CAGR FROM 2014 TO 2019 61
FIGURE 20 ASIAN 4TH GENERATION ELISA MARKET EXPECTED TO DOUBLE BY 2019 79
FIGURE 21 REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE BLOOD SCREENING MARKET DURING FORECAST PERIOD 89
FIGURE 22 ASIA IS THE FASTEST-GROWING REGION IN THE BLOOD SCREENING REAGENT MARKET 90
FIGURE 23 CHINA TO WITNESS THE HIGHEST GROWTH IN THE BLOOD SCREENING NAT REAGENTS MARKET IN ASIA 98
FIGURE 24 BLOOD SCREENING MARKET SEGMENTATION, BY END USER 108
FIGURE 25 BLOOD BANKS SEGMENT WILL CONTINUE TO DOMINATE THE BLOOD SCREENING MARKET DURING THE FORECAST PERIOD 108
FIGURE 26 REGIONALSNAPSHOT: EMERGING MARKETS SUCH AS CHINA, INDIA AND JAPAN OFFER SIGNIFICANT GROWTH OPPORTUNITIES IN THE BLOOD SCREENING MARKET 117
FIGURE 27 NORTH AMERICA: MARKET GROWTH WILL BE DRIVEN BY INNOVATIVE BLOOD SCREENING INSTRUMENTS AND REAGENTS 119
FIGURE 28 CHINA OFFERS IMMENSE GROWTH OPPORTUNITIES FOR THE BLOOD SCREENING MARKET 153
FIGURE 29 NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY LEADING PLAYERS 166
FIGURE 30 BLOOD SCREENING MARKET SHARE ANALYSIS FOR NAT, BY KEY PLAYER, 2014 167
FIGURE 31 BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 168
FIGURE 32 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY 169
FIGURE 33 PRODUCT BENCHMARKING FOR TOP 5 PLAYERS 174
FIGURE 34 GRIFOLS: COMPANY SNAPSHOT 175
FIGURE 35 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 178
FIGURE 36 ABBOTT LABORATORIES: COMPANY SNAPSHOT 181
FIGURE 37 BIOMÉRIEUX: COMPANY SNAPSHOT 184
FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 187
FIGURE 39 SIEMENS AG : COMPANY SNAPSHOT 190
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 194
FIGURE 41 DANAHER CORPORATION: COMPANY SNAPSHOT 196
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 198

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Plasma Fractionation Market by Product, Application, End User - Global Forecast to 2021

Plasma Fractionation Market by Product, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global plasma fractionation market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 26.07 billion by 2021 from USD 18.84 billion in 2016. Growth in this market is mainly attributed ...

Global Market Study on Disposable Blood Bags: Increasing Tender Based Procurement of Blood Collection Bags by Not-For-Profit Organizations and Public Healthcare Facilities to Drive Market by 2024

Global Market Study on Disposable Blood Bags: Increasing Tender Based Procurement of Blood Collection Bags by Not-For-Profit Organizations and Public Healthcare Facilities to Drive Market by 2024

  • $ 4900
  • Industry report
  • September 2016
  • by Persistence Market Research

This Persistence Market Research (PMR) report examines the ‘Global Disposable Plastic Blood Bags Market’ for the period 2016–2024. The primary objective of the report is to offer updates and information ...

2016-2021  Emerging US Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Business Environment, Market Structure

2016-2021 Emerging US Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Business Environment, Market Structure

  • $ 4350
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.